Skip to content

Arterolane

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: arterolane maleate, OZ 277, OZ277

CDSCO (INDIA) approvedATC P01BX02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Arterolane is a drug catalogued in DrugCentral. It was first approved by the CDSCO (INDIA) in 2012. Recorded indications include Falciparum malaria.

  • Indications: Falciparum malaria.
  • ATC code: P01BX02 (Other antimalarials).
  • Molecular formula: C21H34N2O4; molecular weight 378.51 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Falciparum malaria

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2012-03-09CDSCO (INDIA)——

ATC classification

ATC codeTherapeutic hierarchy
P01BX02ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Other antimalarials

Chemical structure

Molecular formulaC21H34N2O4
Molecular weight378.51 g/mol
CAS number664338-39-0
InChIKeyBRJULSXZDFYSPG-MSMJXPJBSA-N
PubChem CID10475633
CC(C)(N)NC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@H]2CC3CC(C2)C[C@H]1C3

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Arterolane used for?

DrugCentral lists the following indications for Arterolane: Falciparum malaria.

When was Arterolane first approved?

Arterolane was first approved by the CDSCO (INDIA) in 2012.

What is the chemical formula of Arterolane?

Arterolane has the molecular formula C21H34N2O4 and a molecular weight of 378.51 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2012-03-09
AgencyCDSCO (INDIA)
Targets0
Indications1
FormulaC21H34N2O4
DrugCentral ID5090
Interactive profile